A Jewish American and a Palestinian American are tackling science’s toughest challenges February 23, 2024
KalVista pill reduces swelling symptoms caused by genetic disease, achieving goal of late-stage study February 23, 2024
KalVista Pharmaceuticals Reports Phase 3 Trial Meets All Endpoints for Sebetralstat as First Oral On-demand Therapy for Hereditary Angioedema February 23, 2024
Be Biopharma Expands Leadership Team as Company Transitions to Clinical Stage Organization January 5, 2024
